Randolph C Read insider trades: Enzon Pharmaceuticals (ENZN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Randolph reports to the SEC
and 1 more company
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | ENZN | ↑ Buy | 99,550 | $0.14 | $14K | Direct | Jun 16, 2023 (0d) |
| Nov 18, 2020 | ENZN | ↑ Buy | 100,450 | $0.15 | $15K | Direct | Nov 18, 2020 (0d) |
| Mar 7, 2019 | SD | ↑ Buy | 15,000 | $7.48 | $112K | Direct | Mar 11, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Randolph C Read's insider trades
Randolph C Read is a director at Enzon Pharmaceuticals (ENZN). Since Mar 7, 2019, Randolph has reported 3 open-market purchases worth $142K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (24 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENZN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.